Matthew B. Lanktree,E. Guiard,P. Akbari,Marina Pourafkari,I. Iliuta,Sohnee Ahmed,Amirreza Haghighi,Ning He,Xuewen Song,Andrew D. Paterson,Korosh Khalili,York Pei
Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly variable between patients. On average, protein-truncating PKD1 mutations are associated with the most severe kidney disease among all mutation classes, yet within family disease variability is a recognized feature of ADPKD. The penetrance of protein-truncating PKD1 mutations cannot be adequately evaluated if only index probands with severe disease are tested. Here, we evaluated the patients with protein-truncating PKD1 mutations yet mild kidney disease from the extended Toronto Genetic Epidemiologic Study of Polycystic Kidney Disease.